Protagonist Therapeutics
Price & Volume
Stats
See more52W Range | $62.24-$160.81 |
Market Cap | $9.1B |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $281.9M |
Revenue Growth (YoY) | 3,749.2% |
Gross Profit (12 Mos) | $281.9M |
Diluted EPS | $1.01 |
News
See moreYahoo Finance • 10 days ago
Psoriatic Arthritis Market Landscape: 6 Key Late-Stage Drugs Set to Drive Future Growth | DelveInsight
Yahoo Finance • 13 days ago
J&J Up 18% in Three Months: Buy, Sell or Hold the Stock?
Yahoo Finance • 23 days ago
Protagonist Therapeutics Announces $300 Million Share Repurchase Program
Yahoo Finance • 27 days ago
MIMRYLO Approval Triggered $275M Payments for Protagonist (PTGX). Are Royalties the Better Commercial Model?
About
CEO | Dr. Dinesh V. Patel Ph.D. |
CFO | Mr. Asif Ali |
Address | 7707 Gateway Boulevard, Newark, CA, United States, 94560 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 141 |